Source: International Congress 2016 – Orphan diseases I
Disease area: Interstitial lung diseases



Rating:

Share or cite this content

Citations should be made in the following way:
Silvia Terraneo (Arosio, Italy), Fabiano Di Marco, Silvia Terraneo, Giuseppina Palumbo, Gianluca Imeri, Francesca La Briola, Silvia Tresoldi, Angela Volpi, Lorenzo Gualandri, Filippo Ghelma, Rosa Maria Alfano, Emanuele Montanari, Alfredo Gorio, Elena Lesma, Angela Peron, Maria Paola Canevini, Stefano Centanni. Pulmonary function tests for lymphangioleiomyomatosis screening in women with tuberous sclerosis complex. Eur Respir J 2016; 48: Suppl. 60, 3874

Member's Comments

No comment yet.

Related content which might interest you: Pulmonary function tests as outcomes for systemic sclerosis interstitial lung disease Source: Eur Respir Rev, 27 (148) 170102; 10.1183/16000617.0102-2017 Year: 2018 Pulmonary function in patients with sporadic lymphangioleiomyomatosis. Source: Virtual Congress 2021 – Future advances in respiratory physiology Year: 2021 Alk-rearranged adenocarcinoma arising in lung lymphangioleiomyomatosis of a patient with tuberous sclerosis complex Source: International Congress 2019 – Lung cancer? Year: 2019 Severity and outcome of cystic lung disease in women with tuberous sclerosis complex Source: Eur Respir J 2015; 45: 171-180 Year: 2015 Pulmonary function tests as predictors of mortality in patients with sarcoidosis Source: International Congress 2015 – Sarcoidosis: clinical Year: 2015 Pulmonary function in progressive systemic sclerosis Source: Eur Respir J 2002; 20: Suppl. 38, 62s Year: 2002 Pulmonary function tests in childhood scleroderma Source: Eur Respir J 2006; 28: Suppl. 50, 307s Year: 2006 Interstitial lung involvement in systemic sclerosis. Correlation of HRCT and lung function tests Source: Eur Respir J 2004; 24: Suppl. 48, 487s Year: 2004 Lung function and pulmonary hypertension in systemic sclerosis Source: Eur Respir J 2006; 28: Suppl. 50, 548s Year: 2006 Interstitial lung disease in systemic sclerosis: where do we stand? Source: Eur Respir Rev 2015; 24: 411-419 Year: 2015 Longitudinal functional evaluation of interstitial lung disease in systemic sclerosis Source: Virtual Congress 2020 – Diagnostic and prognostic markers for disease-associated interstitial lung disease and hypersensitivity pneumonitis Year: 2020 Hemoptysis: rare pulmonary manifestation of tuberous sclerosis in childhood Source: Eur Respir J 2006; 28: Suppl. 50, 544s Year: 2006 Pulmonary involvement in systemic sclerosis Source: Eur Respir Monogr 2019; 86: 90-105 Year: 2019 Pulmonary function testing in children's interstitial lung disease Source: Eur Respir Rev, 29 (157) 200019; 10.1183/16000617.0019-2020 Year: 2020 Comparison of physiological impairment in ILD patients with and without diagnostic IPF features Source: International Congress 2014 – ILDs 4 Year: 2014 Variation in mortality from interstitial lung disease by diagnosis Source: International Congress 2015 – IIPs: orphan Year: 2015 Pulmonary function involvement in scleroderma Source: Annual Congress 2013 –Diffuse parenchymal lung disease II Year: 2013 Pulmonary functions in systemic sclerosis Source: Annual Congress 2012 - Diffuse parenchymal lung disease III Year: 2012 Respiratory function in systemic sclerosis patients Source: International Congress 2015 – Lung function: exploring the boundaries of the respiratory system Year: 2015 Familial pulmonary fibrosis: Respiratory function progression analysis in different HRCT patterns Source: International Congress 2015 – IPF: clinical aspects II Year: 2015